Video from the last years ESC congress, highlighting the insights into the AFFECT-EU showcaseing the project was published on its official Youtube channen. The congress hosted a borad spectrum of stakeholders in attendence, exposing them to to the AFFECT-EU project.
To watch the complete video, click here.
''It's critical to be radical!''
It’s official! 2024 Radical Health Festival, taking place in Helsinki on 21-23 May!
The future of health and care lies at the intersection of prevention and precision. It’s a paradigm shift that requires vision, leadership, change management and the critical need to be radical.
One of the speakers at the Festival will be the Professor Renate Schnabel, who played pivotal role in the realization and delivery of the AFFECT-EU project with her brilliant work.
To find out more about the festival and the program, click here.
The AFFECT-EU consortium is organising its Final Conference on Monday 18 March 2024 at the De Warande Club in Brussels, Rue Zinner 1, 1000 Bruxelles. This event will gather representatives from researchers, notified bodies, researchers, industry but also patients and healthcare professionals. It will notably contribute to share its insights on the research and findings revolving around Atrial Fibrilation Screening based on the work done by partners of the Consortium.
The Conference objectives are
The full programme of this event is available here
The venue for our final public event can accommodate approx. 100 people. Attendance is free, on a first-come-first-served basis, and there will also be a live webcast so that online participation will be possible for anyone who has pre-registered.
Coral Hanson
Senior Research Fellow - Edinburgh Napier University (NAPIER)
Could you tell us a bit about yourself?
I graduated from Newcastle Polytechnic in 1991 and received my doctoral degree from Durham University in 2017. I am a senior research fellow in the Centre for Cardiovascular Health at Edinburgh Napier University. My research is focused on understanding the reasons why people do, or do not take part in interventions (such as AF screening).
Could you tell us more about your organization?
Edinburgh Napier University is a modern university in Scotland. We pride ourselves on being an enterprising and innovative community, with more than 300 undergraduate and postgraduate courses and nearly 20,000 students from over 140 countries studying on campus in Edinburgh, online and at partner universities worldwide.
What is your role in the project?
I am a member of the WP 5 team and have been involved in a qualitative study about stakeholder views about AF screening across Europe and a realist review of what works, for whom and why for AF screening.
When did you get involved in AFFECT-EU?
I became involved in AFFECT-EU through my work as part of the Centre for Cardiovascular Health Team working for Professor Lis Neubeck, who is an expert in AF screening.
How did you become interested in AF screening?
Previously I have worked in and undertaken research about cardiac rehabilitation. I became aware that people living with AF were not always eligible for cardiac rehabilitation and from this became interested in screening and lifestyle interventions for AF.
Can you describe your work and how it is related to AFFECT-EU?
I have applied a social science perspective to explore what groups of people access AF screening and the reasons for this, and how this affects screening yield. This has allowed us to develop evidence-based recommendations about how AF screening programmes should plan services to be delivered in locations that are accessible to those most at risk of undiagnosed AF using targeted and inclusive invitations. There is a need to provide training to increase screener understanding of who screen and competence to use digital technology for screening. We have also recommended that organisations should ensure that there are support mechanisms such as automated prompts to increase awareness of who to screen, and that there are standardised follow-up pathways.
How will participation in AFFECT-EU change your professional life?
Participation in AFFECT-EU has widened my professional circle and has allowed me to develop new collaborative partnerships for future work.
Could you tell us a bit about yourself?
I graduated from Newcastle Polytechnic in 1991 and received my doctoral degree from Durham University in 2017. I am a senior research fellow in the Centre for Cardiovascular Health at Edinburgh Napier University. My research is focused on understanding the reasons why people do, or do not take part in interventions (such as AF screening).
Could you tell us more about your organization?
Edinburgh Napier University is a modern university in Scotland. We pride ourselves on being an enterprising and innovative community, with more than 300 undergraduate and postgraduate courses and nearly 20,000 students from over 140 countries studying on campus in Edinburgh, online and at partner universities worldwide.
What is your role in the project?
I am a member of the WP 5 team and have been involved in a qualitative study about stakeholder views about AF screening across Europe and a realist review of what works, for whom and why for AF screening.
When did you get involved in AFFECT-EU?
I became involved in AFFECT-EU through my work as part of the Centre for Cardiovascular Health Team working for Professor Lis Neubeck, who is an expert in AF screening.
How did you become interested in AF screening?
Previously I have worked in and undertaken research about cardiac rehabilitation. I became aware that people living with AF were not always eligible for cardiac rehabilitation and from this became interested in screening and lifestyle interventions for AF.
Can you describe your work and how it is related to AFFECT-EU?
I have applied a social science perspective to explore what groups of people access AF screening and the reasons for this, and how this affects screening yield. This has allowed us to develop evidence-based recommendations about how AF screening programmes should plan services to be delivered in locations that are accessible to those most at risk of undiagnosed AF using targeted and inclusive invitations. There is a need to provide training to increase screener understanding of who screen and competence to use digital technology for screening. We have also recommended that organisations should ensure that there are support mechanisms such as automated prompts to increase awareness of who to screen, and that there are standardised follow-up pathways.
How will participation in AFFECT-EU change your professional life?
Participation in AFFECT-EU has widened my professional circle and has allowed me to develop new collaborative partnerships for future work.
Do you have any predictions for the future of AF screening?
I am confident that AF screening will be used in the future but think it should target those population groups that are most likely to have undiagnosed AF (e.g., those who live in areas of social deprivation or who currently do not engage with primary care). More work is required to understand how best to target these groups.
Webinars
This webinar is designed for general practitioners, EHRA members, ACNAP members, members of the ESC Council on Stroke and the ESC Council on Cardiology Practice, preventive cardiologists, and those wishing to update their scientific knowledge on the topic.
Rhythm monitoring: new technologies, new strategies - a Horizon 2020 AFFECT-EU
This webinar addresses the looming arrhythmia epidemic caused by demographic changes, set to double by 2050. It explores cutting-edge technologies like biomarkers, imaging, and AI-driven ECG interpretation for early detection.This webinar allows general practitioners, EHRA members, ACNAP members, members of the ESC Council on Stroke and the ESC Council on Cardiology Practice, preventive cardiologists, and those wishing to learn more about the validity of wearable devices and their role in virtual care pathways, all while staying up-to-date on the latest evidence and guidelines.
Open access deliverables
Overview of ongoing and completed AF screening studies - D1.1
Catalogue detailing the available datasets and associated variables in the consortium - D1.2
Systematic review of economic evaluations literature of AF screening - D4.1
Patient engagement
StopAfib.org is a patient-to-patient resource to share experiences and lessons learned.
The afibmatters.org website has been developed under the direction of the European Heart Rhythm Association of the European Society of Cardiology (EHRA of the ESC). The aim of the website is to provide clear and reliable information and practical advice to people with atrial fibrillation, their families and caregivers.
Die Deutsche Herzstiftung (German Heart Foundation)
The German Heart Foundation offers patients information on all questions around cardiovascular diseases. An online consultation as well as a doctors and self-help groups search are part of the services offered by the patient organisation.
AFFECT-EU receiving funding from the European Union’s Horizon 2020 research and innovation Programme under grant agreement N°847770. This reflects the authors’ view only. The Commission is not responsible for any use that may be made of the information it contains.
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic through Google Analytics. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.
